Intercept Pharmaceuticals, Inc Earning Date (ICPT)

USA |NASDAQ |USD

ICPT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 23, 2022 Dec 2021 $-1.42 - $-1.58
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 23, 2022 Dec 2021 $79.21M - $83.27M

Intercept Pharmaceuticals, Inc's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 2021.

ICPT Earnings Date & History Chart

ICPT Earnings & Revenue Forecast

ICPT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 17 $-1.42 $-2.64 $-0.71
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 16 $-4.03 $-5.48 $-3.02
Dec 2022 18 $-4.83 $-10.51 $-1.55

ICPT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 1 $-1.45 $-1.37 $-1.13
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 3 / 0 $-4.08 $-4.06 $-4.74
Dec 2022 2 / 1 $-5.08 $-4.81 $-4.96

ICPT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 18 $79.21M $69.01M $85.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 18 $339.04M $329.44M $350.10M
Dec 2022 18 $343.75M $100.30M $429.08M

ICPT Earnings Date & Revenue History

ICPT Earnings History

|
Show More
Show More

ICPT Revenue History

|
Show More
Show More

Intercept Pharmaceuticals, Inc Next Earnings Date & Report

ICPT Next Earnings Date & Report Preview: Dec 2021 (FQ)

ICPT's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for Intercept Pharmaceuticals, Inc's next quarterly earnings is $-1.42, with a low EPS estimation of $-2.64, and a high estimation of $-0.71.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 1 downward. The EPS 1 month trend is $-1.45, the last 2 month trend is $-1.37, and the 3 month trend is $-1.13.

Based on analysts, the average revenue estimation is $79.21M, with a low revenue estimation of $69.01M, and a high estimation of $85.00M.

Intercept Pharmaceuticals, Inc Previous Earnings Dates & Reports

ICPT Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Intercept Pharmaceuticals, Inc's previous earnings date was Nov 8, 2021 for its fiscal quarter ended Sep 30, 2021.

ICPT Previous Earnings Date & Report Recap: Dec 2020 (FY)

Intercept Pharmaceuticals, Inc's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

ICPT's earnings per share (EPS) was $-7.97, beating the consensus analysts forecast of $-8.18 by -2.58% , and higher than the previous year's EPS (Dec 2019) by -26.82%.

Revenues were $312.69M, worse than the forecast of $314.46M by -0.56%, and up by 24.08% from previous year's revenue.

The company reported a net income of $-274.88M.

Intercept Pharmaceuticals, Inc reported a free cash flow of $-173.92M for its fiscal year, compared to $-237.75M a year ago.

The company ended the fiscal year with $567.83M in total debt, an increase of 5.44% compared to the previous year.